Breaking News Instant updates and real-time market news.

SAVE

Spirit Airlines

$40.08

0.59 (1.49%)

, WCC

Wesco

$65.95

0.05 (0.08%)

07:51
02/27/18
02/27
07:51
02/27/18
07:51

Wolfe Research to hold a conference

Smart Ideas 1:1 Conference to be held in London, England on February 27.

SAVE

Spirit Airlines

$40.08

0.59 (1.49%)

WCC

Wesco

$65.95

0.05 (0.08%)

GDI

Gardner Denver

$33.00

0.12 (0.36%)

BHGE

Baker Hughes

$27.63

-0.4 (-1.43%)

DK

Delek US

$34.03

-0.23 (-0.67%)

OXY

Occidental Petroleum

$67.27

-1.05 (-1.54%)

RSPP

RSP Permian

$36.70

-0.53 (-1.42%)

SLB

Schlumberger

$66.73

0.23 (0.35%)

LVS

Las Vegas Sands

$73.95

-0.38 (-0.51%)

HAIN

Hain Celestial

$35.04

0.19 (0.55%)

GWR

Genesee & Wyoming

$72.92

1.32 (1.84%)

AWK

American Water

$80.80

0.17 (0.21%)

EXC

Exelon

$38.03

-0.21 (-0.55%)

NEE

NextEra Energy

$154.65

-0.5 (-0.32%)

NEP

NextEra Energy Partners

$39.54

-0.36 (-0.90%)

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 11

    Mar

  • 13

    Mar

  • 23

    Mar

  • 26

    Mar

  • 20

    Apr

  • 15

    May

  • 30

    May

SAVE Spirit Airlines
$40.08

0.59 (1.49%)

01/16/18
01/16/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Under Armour (UA, UAA) downgraded to Underperform from Neutral at Macquarie with analyst Laurent Vasilescu citing weaker North America revenues, flat Connected Fitness revenues, international revenues of up 21% year-over-year, gross margin pressure, and higher SG&A assumptions. 2. Verizon (VZ) downgraded to Neutral from Buy at MoffettNathanson. 3. Lockheed Martin (LMT) and Rockwell Collins (COL) were downgraded to Market Perform from Outperform at Wells Fargo. 4. Spirit Airlines (SAVE) downgraded to Hold from Buy at Stifel with analyst Joseph DeNardi saying he believes Spirit will benefit this year from an improving demand and revenue environment, but that its higher revenue risk relative to potential competitive responses to its expected capacity growth is not fully reflected in the stock at current levels. 5. Finisar (FNSR) downgraded to Sell from Neutral at Goldman Sachs with analyst Doug Clark saying risks of oversupply and competition are heating up in the optical component landscape. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/07/18
MACQ
02/07/18
UPGRADE
Target $57
MACQ
Outperform
Spirit Airlines upgraded to Outperform from Neutral at Macquarie
Macquarie analyst Susan Donofrio upgraded Spirit Airlines to Outperform with a $57 price target saying the tentative pilot's agreement removes an uncertainty and the current environment of less aggressive competitive pricing actions is a positive.
02/07/18
02/07/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Lennar (LEN) upgraded to Overweight from Equal Weight at Barclays with analyst Michael Dahl saying he now expects higher returns, margins and growth, and thinks "strong" free cash flow" creates balance sheet optionality. 2. Chevron (CVX) upgraded to Outperform from Market Perform at Wells Fargo with analyst Roger Read saying he believes the energy sector's potential combination of growth and returns is attractive and could drive better shareholder returns in 2018. 3. Wynn Resorts (WYNN) was upgraded to Overweight from Neutral at JPMorgan and to Buy from Neutral at Nomura Instinet. 4. Snap (SNAP) was upgraded to Buy from Neutral at BofA/Merrill, to Hold from Sell at SunTrust, to Neutral from Underweight at JPMorgan, to In Line from Underperform at Evercore ISI, and to Outperform from Sector Perform at RBC Capital. 5. Spirit Airlines (SAVE) was upgraded to Outperform from Neutral at Macquarie and to Outperform from In-Line at Imperial Capital. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/07/18
IMPC
02/07/18
UPGRADE
Target $49
IMPC
Outperform
Spirit Airlines upgraded to Outperform from In-Line at Imperial Capital
Imperial Capital analyst Michael Derchin upgraded Spirit Airlines to Outperform and raised his price target for the shares to $49 from $42. The shares are fully discounting the impact from the potential contract with the pilots and the competitive situation with United Continental (UAL), Derchin tells investors in a research note. The analyst sees upside from "strong" ancillary revenues, operational improvements, and decelerating capacity growth.
WCC Wesco
$65.95

0.05 (0.08%)

01/23/18
UBSW
01/23/18
INITIATION
Target $70
UBSW
Neutral
Wesco initiated with a Neutral at UBS
UBS analyst Christopher Belfiore initiated Wesco with a Neutral rating and $70 price target.
10/18/17
STPT
10/18/17
DOWNGRADE
STPT
Hold
Wesco downgraded to Hold on valuation at Standpoint Research
Standpoint Research analyst Ronnie Moas downgraded Wesco to Hold from Buy with the stock up 20% since his early August recommendation. The analyst views the stock as fairly valued at current levels and prefers the low $50's as an entry point.
10/27/17
WOLF
10/27/17
DOWNGRADE
WOLF
Peer Perform
Wesco downgraded to Peer Perform from Outperform at Wolfe Research
10/31/17
FBCO
10/31/17
NO CHANGE
Target $70
FBCO
Outperform
Wesco price target raised to $70 from $64 at Credit Suisse
Credit Suisse analyst Andrew Buscaglia raised his price target for Wesco to $70 from $64 following quarterly results. The analyst reiterates an Outperform rating on the shares.
GDI Gardner Denver
$33.00

0.12 (0.36%)

12/15/17
DBAB
12/15/17
NO CHANGE
Target $36
DBAB
Buy
Gardner Denver price target raised to $36 from $30 at Deutsche Bank
Deutsche Bank analyst John Inch raised his price target for Gardner Denver to $36 citing the "strong" Q3 results and recent strength in oil prices. The analyst sees 2018 to being another strong year for Gardner's Energy business. He keeps a Buy rating on the shares.
02/15/18
LEHM
02/15/18
INITIATION
Target $35
LEHM
Equal Weight
Gardner Denver initiated with an Equal Weight at Barclays
Barclays analyst Julian Mitchell started Gardner Denver with an Equal Weight rating and $35 price target. The analyst initiated 24 Multi-Industry companies with a Neutral sector view.
09/26/17
PIPR
09/26/17
NO CHANGE
Target $31
PIPR
Overweight
Gardner Denver remains a top pick at Piper Jaffray
Piper Jaffray analyst Bill Herbert says Gardner Denver Holdings remains a top pick. A tour of the company's "substantial" Permian facility indicated the frac complex remains tight given continued robust completions demand, Herbert tells investors in a research note. He keeps an Overweight rating on the shares with a $31 price target.
01/23/18
UBSW
01/23/18
INITIATION
Target $42
UBSW
Buy
Gardner Denver initiated with a Buy at UBS
UBS analyst Damian Karas initiated Gardner Denver with a Buy rating and $42 price target.
BHGE Baker Hughes
$27.63

-0.4 (-1.43%)

02/26/18
02/26/18
UPGRADE
Target $33

Neutral
Baker Hughes upgraded to Neutral on pullback at BofA/Merrill
As previously reported, BofA/Merrill upgraded Baker Hughes to Neutral from Underperform and trimmed its price target to $33 from $35. Analyst Timna Tanners said shares underperformed peers over the past 6 months and are a better value now that expectations have been reduced. Further, he expects solid 2019 international outlook.
02/26/18
BOFA
02/26/18
UPGRADE
BOFA
Neutral
Baker Hughes upgraded to Neutral from Underperform at BofA/Merrill
02/01/18
02/01/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. eBay (EBAY) upgraded to Outperform from Sector Perform at RBC Capital with analyst Mark Mahaney citing the "ongoing acceleration in Marketplace gross merchandise volume, the surprise announcement that eBay will intermediate payments, and materially ramped up share repurchases." 2. Textron (TXT) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Rajeev Lalwani citing the growing chances he sees of a bizjet recovery, the stock's relative underperformance over the last year and upside levers that include R&D cuts, M&A, or more capital returns. 3. Invesco (IVZ) upgraded to Outperform from Neutral at Credit Suisse with analyst Craig Siegenthaler saying the operating expense reset with yesterday's fourth quarter results, recent sell-side downgrades, and share price underperformance over the last six months presents an upgrade opportunity and attractive valuation. 4. Baker Hughes (BHGE) upgraded to Neutral from Sell at Goldman Sachs with analyst Waqar Syed saying he believes expectations have been reset lower over the last six months and highlights his firm's more favorable commodity price outlook. 5. AMD (AMD) upgraded to Buy from Hold at Argus with analyst Jim Kelleher saying the latest quarterly results demonstrate the "sustainability of the company's return to consistent profitability and top and bottom-line growth." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/12/18
RBCM
02/12/18
NO CHANGE
Target $30
RBCM
Outperform
Baker Hughes price target lowered to $30 from $35 at RBC Capital
RBC Capital analyst Kurt Hallead lowered his price target on Baker Hughes to $30, citing the company's lower margin guidance in its TPS business which also reduced consensus estimates. The analyst keeps his Outperform rating on the company, noting potential catalysts that include acceleration in the global energy expenditures, higher than expected increase in international drilling, and acceleration in Subsea and LNG FIDs.
DK Delek US
$34.03

-0.23 (-0.67%)

01/11/18
01/11/18
UPGRADE
Target $44

Overweight
Delek US upgraded to Overweight at Morgan Stanley
As previously reported, Morgan Stanley analyst Benny Wong upgraded Delek US to Overweight from Equal Weight, saying he sees the company as positioned for better relative refining earnings given its locational advantage in the Permian. He also sees Delek US as quickly moving into a position to offer higher cash returns. Wong raised his price target on the stock to $44 from $34.
02/14/18
SBSH
02/14/18
UPGRADE
Target $43
SBSH
Buy
Delek US upgraded to Buy from Neutral at Citi
Citi analyst Prashant Rao upgraded Delek US to Buy after taking over coverage of the name. The analyst believes favorable Permian economics will drive "meaningful" free cash flow through 2020. He raised his price target for the shares to $43 from $41.
02/15/18
BOFA
02/15/18
UPGRADE
BOFA
Neutral
Delek US upgraded to Neutral on stabilizing spreads at BofA/Merrill
BofA/Merrill analyst Doug Leggate upgraded Delek US to Neutral from Underperform and increased its price target to $37 to reflect stabilizing spreads, recent asset sales, and share buy backs.
01/11/18
MSCO
01/11/18
UPGRADE
MSCO
Overweight
Delek US upgraded to Overweight from Equal Weight at Morgan Stanley
OXY Occidental Petroleum
$67.27

-1.05 (-1.54%)

01/22/18
SBSH
01/22/18
UPGRADE
Target $73
SBSH
Neutral
Occidental Petroleum upgraded to Neutral from Sell at Citi
Citi analyst Robert Morris upgraded Occidental Petroleum (OXY) to Neutral and raised his price target for the shares to $73 from $64. The upgrades follows the analyst's estimate increases last week. His highest conviction pair trade into Q4 earnings is long Occidental versus Hess Corp. (HES). He expects Hess to miss on production and to lower its 2018 guidance due to shut-ins in the deepwater Gulf of Mexico and weather-related issues in the Bakken. Occidental, on the other hand, is "hitting on all cylinders," Morris writes.
01/17/18
MACQ
01/17/18
INITIATION
Target $75
MACQ
Neutral
Occidental Petroleum initiated with a Neutral at Macquarie
Macquarie analyst Kate Sloan initiated Occidental Petroleum with a Neutral and $75 price target. Sloan said Occidental has a high break-even and does not cover its dividend at current oil forecasts.
01/04/18
BOFA
01/04/18
DOWNGRADE
Target $80
BOFA
Neutral
Occidental Petroleum downgraded to Neutral on valuation at BofA/Merrill
As previously reported, BofA/Merrill downgraded Occidental Petroleum to Neutral from Buy and increased its price target to $80 from $79. Analyst Doug Leggate said the strong recovery in shares appropriately values lower US corporate taxes in its domestic Chemicals and midstream business.
01/04/18
BOFA
01/04/18
DOWNGRADE
BOFA
Neutral
Occidental Petroleum downgraded to Neutral from Buy at BofA/Merrill
RSPP RSP Permian
$36.70

-0.53 (-1.42%)

01/23/18
FBCO
01/23/18
NO CHANGE
Target $51
FBCO
Outperform
RSP Permian price target raised to $51 from $44 at Credit Suisse
Credit Suisse analyst Betty Jiang raised her price target for RSP Permian to $51 from $44 on valuation. The analyst reiterates an Outperform rating on the shares.
01/29/18
JRCO
01/29/18
UPGRADE
JRCO
Buy
RSP Permian upgraded to Buy from Accumulate at Johnson Rice
01/22/18
ROTH
01/22/18
NO CHANGE
Target $50.5
ROTH
Buy
RSP Permian price target raised to $50.50 from $44 at Roth Capital
Roth Capital analyst John White raised his price target for RSP Permian to $50.50 from $44 on higher 2018 WTI crude oil price estimates. The analyst reiterates a Buy rating on the shares.
02/01/18
DBAB
02/01/18
INITIATION
Target $55
DBAB
Buy
RSP Permian initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Nitin Kumar started RSP Permian with a Buy rating and $55 price target.
SLB Schlumberger
$66.73

0.23 (0.35%)

02/27/18
BOFA
02/27/18
NO CHANGE
BOFA
Schlumberger added to the US 1 List. Patterson-UTI removed at BofA/Merrill
02/26/18
BOFA
02/26/18
UPGRADE
Target $79
BOFA
Buy
Schlumberger upgraded to Buy on international activity at BofA/Merrill
As previously reported, BofA/Merrill upgraded Schlumberger (SLB) to Buy from Neutral and trimmed its price target to $75 from $79. Analyst Timna Tanners said shares underperformed and fund ownership fell in 2017 as investor focus shifted towards more shale-focused names. Tanners believes the oil/gas price recovery cycle will shift focus to International with activity slowing recovering and pricing firming more in 2019. Further, the analyst believes SPM's contribution is underappreciated and expects a project payoff and/or stake sale in 2019.
02/26/18
BOFA
02/26/18
UPGRADE
BOFA
Buy
Schlumberger upgraded to Buy from Neutral at BofA/Merrill
02/26/18
02/26/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. UPS (UPS) upgraded to Buy from Hold at Loop Capital by analyst Rick Paterson, who attributed the recent selloff, in part, to news on February 9 that Amazon (AMZN) plans to offer some limited parcel delivery services to third parties. The analyst believes concerns around Amazon "may be a little overblown." Paterson believes Amazon represents about 4%-6% of "lower margin" revenues at UPS. If all of that is ultimately brought into Amazon's own network, "that's hardly a disaster," he contended. 2. Schlumberger (SLB) upgraded to Buy from Neutral at BofA/Merrill by analyst Timna Tanners, who said shares underperformed and fund ownership fell in 2017 as investor focus shifted towards more shale-focused names. Tanners believes the oil/gas price recovery cycle will shift focus to International with activity slowing recovering and pricing firming more in 2019. Further, the analyst believes SPM's contribution is underappreciated and expects a project payoff and/or stake sale in 2019. 3. HP Inc (HPQ) upgraded to Overweight from Neutral at JPMorgan by analyst Paul Coster, who cited valuation following the company's Q1 results. The analyst believes the shares may now look attractive for value investors and sees U.S. tax reform and foreign currency moves as tailwinds. 4. Finish Line (FINL) upgraded to Positive from Neutral at Susquehanna by analyst Sam Poser, who said channel checks indicate that sales and promotional trends in Q4 were not as bad as its guidance anticipated. He believes management has better positioned the company's marketing and promotional calendar as an adjustment to the late tax refund checks. 5. Duke Energy (DUK) upgraded to Buy from Hold at Deutsche Bank (DB) by analyst Jonathan Arnold, who said Friday's constructive order from the North Carolina Utilities Commission in the Duke Energy Progress rate case effectively allows recovery of a majority of the utility's historical costs related to coal ash basin closures. He sees the order as largely resolving the outstanding regulatory risk associated with coal ash cost recovery in North Carolina and likely offering a positive read-across to the larger Duke Energy Carolinas rate case. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
LVS Las Vegas Sands
$73.95

-0.38 (-0.51%)

01/25/18
STFL
01/25/18
NO CHANGE
Target $88
STFL
Buy
Las Vegas Sands positives far outweighed negatives in Q4, says Stifel
Stifel analyst Steven Wieczynski said that while Las Vegas Sands' Q4 report was "not entirely favorable," he believes the positives far outweighed the negatives. He points toward hold-normalized EBITDA growth of 30%, the fact that hold-normalized margins grew to 35.1%, which was well ahead of the consensus view of 34.7%, and that management consistently reiterated on the earnings call that things in Macau "feel different today" with a deeper and more diversified guest pool. Wieczynski keeps a Buy rating on the stock and raised his price target to $88 from $76.
01/18/18
JEFF
01/18/18
INITIATION
Target $73
JEFF
Hold
Las Vegas Sands initiated with a Hold at Jefferies
Jefferies analyst David Katz initiated Las Vegas Sands with a Hold rating and $73 price target.
01/25/18
ROTH
01/25/18
NO CHANGE
Target $85
ROTH
Buy
Las Vegas Sands price target raised to $85 from $69 at Roth Capital
Roth Capital analyst David Bain raised his price target for Las Vegas Sands to $85 from $69 as he believes it is best positioned to capture near-term visitation influx from the opening of the HZM Bridge in mid-2018. The analyst reiterates a Buy rating on the shares.
01/25/18
LEHM
01/25/18
NO CHANGE
Target $85
LEHM
Overweight
Las Vegas Sands price target raised to $85 from $75 at Barclays
Barclays analyst Felicia Hendrix raised her price target for Las Vegas Sands to $85 saying "impressive" growth in the premium mass segment and "favorable flow through" in Macau drove upside to EBITDA in Q4. Looking forward, Las Vegas Sands sees continued near and longer term momentum in Macau, Hendrix tells investors in a research note titled "Mass-ively Well Positioned." The analyst keeps an Overweight rating on the shares.
HAIN Hain Celestial
$35.04

0.19 (0.55%)

12/19/17
MAXM
12/19/17
NO CHANGE
MAXM
Buy
Hain Celestial could be attractive target for CPG manufacturers, says Maxim
Maxim notes that it has observed consolidation in the consumer-packaged goods industry over the past three months, particularly in the area of healthy snacking. Seeing Hain Celestial as a leading producer of better-for-you snacks, the firm believes the company could be an attractive acquisition target for consumer-packaged goods manufacturers seeking to take advantage of the health and wellness trend within snack foods. Based on Maxim's analysis of comparable transactions, it thinks the starting point for a potential acquisition of Hain would be $55-$60 per share.
02/08/18
BMOC
02/08/18
NO CHANGE
Target $39
BMOC
Market Perform
Hain Celestial price target lowered to $39 from $44 at BMO Capital
BMO Capital analyst Amit Sharma lowered his price target on Hain Celestial to $39 after a Q2 earnings miss. Sharma says the company's FY18 EBITDA guidance, which assumes a "huge margin ramp" in the second half of the year, is unrealistic in light of "rising commodity and freight inflation, unfavorable product mix, and potentially higher investments". The analyst keeps his Market Perform rating on Hain Celestial.
11/21/17
WELS
11/21/17
NO CHANGE
WELS
Nestle acquisition of Hain makes sense, says Wells Fargo
Wells Fargo analyst John Baumgartner believes a Nestle (NSRGY) acquisition of Hain Celestial (HAIN) would make sense. Bloomberg last night reported that Nestle is among the companies exploring a purchase of Hain. Nestle would likely be a good fit for Hain's baby food, skin care and tea businesses, Baumgartner told investors earlier in a research note. The analyst sees "tax leakage" as a headwind for any deal and keeps a Market Perform rating on Hain with a $38 price target.
12/22/17
LOOP
12/22/17
NO CHANGE
Target $38
LOOP
Hold
Hain unlikely to receive premium in a takeover, says Loop Capital
Following the acquisitions of Amplify Snack Brands (BETR) and Snyder's-Lance (LNCE), Loop Capital analyst Andrew Wolf revisited his outlook for Hain Celestial Group (HAIN) as an acquisition candidate. The analyst's sum-of-the-parts valuation range for the company remains at $42 to $56 per share, representing a premium range of 1% to 35% to the current share price. Hain, however, is not likely to receive much of a premium valuation in a takeout because its core domestic business is barely growing, in contrast to the companies that have been acquired, Wolf tells investors in a research note. He keeps a Hold rating on the stock with a $38 price target.
GWR Genesee & Wyoming
$72.92

1.32 (1.84%)

01/09/18
01/09/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Ormat Technologies (ORA) initiated with a Buy at Guggenheim. 2. Chaparral Energy (CHPE) initiated with an Outperform at Imperial Capital. 3. Genesee & Wyoming (GWR) initiated with an Overweight at JPMorgan. 4. Newmark (NMRK) was initiated with a Buy at Sandler O'Neill, BofA/Merrill, and Goldman Sachs, as well as an Outperform at Wedbush. 5. Casa Systems (CASA) was initiated with an Outperform at Northland, William Blair, and Raymond James, a Buy at Stifel, as well as an Equal Weight at Morgan Stanley and Barclays. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/12/18
FBCO
02/12/18
NO CHANGE
Target $80
FBCO
Outperform
Genesee & Wyoming price target lowered to $80 form $94 at Credit Suisse
Credit Suisse analyst Allison Landry lowered her price target for Genesee & Wyoming to $80 from $94 following quarterly results. Although Genesee's 2018 EBIT guidance came in lighter than the analyst had expected, she notes that the benefits of the tight TL market have already begun to materialize in the form of carload conversions and improved core pricing. From an M&A standpoint, Landry points out that management indicated that it is seeing the most opportunities for possible acquisitions in N. America. The analyst reiterates an Outperform rating on the shares.
01/11/18
JPMS
01/11/18
DOWNGRADE
Target $123
JPMS
Neutral
J.B. Hunt downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Brian Ossenbeck downgraded J.B. Hunt (JBHT) to Neutral while raising his price target for the shares to $123 from $120. The analyst sees high rate expectations in the first half of 2018 as well as a "full" valuation when adjusting for the benefits of tax reform. He recommends taking profits at current share levels. Ossenbeck is more positive on Genesee & Wyoming (GWR), XPO Logistics (XPO) and Canadian Pacific (CP). He raised his price target for Overweight-rated XPO to $110 from $85.
01/16/18
SUSQ
01/16/18
NO CHANGE
SUSQ
Rail stocks cheaper than they appear, says Susquehanna
Susquehanna analyst Bascome Majors said he likes the rails into 2018, citing the potential for volume-led revisions and possible inflection in free cash flow. He sees the rails as well positioned from multiple cyclical tailwinds, including improved outlooks for core industrial and consumer markets, inflationary pricing, a capacity constrained truckload environment, and a federal infrastructure package that could potentially drive incremental demand. Majors likes CSX (CSX), Union Pacific (UNP), Norfolk Southern (NSC) and Genesee & Wyoming (GWR) shares.
AWK American Water
$80.80

0.17 (0.21%)

02/26/18
WELS
02/26/18
DOWNGRADE
Target $37
WELS
Market Perform
Aqua America downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Jonathan Reeder downgraded Aqua America (WTR) to Market Perform and lowered his price target for the shares to $37 from $43. The analyst cites valuation for the downgrade and prefers shares of American Water (AWK) at current levels.
01/11/18
01/11/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Akamai (AKAM) downgraded to Underweight from Sector Weight at KeyBanc with analyst Brandon Nispel saying activist Elliot Management's involvement as well Akamai's own strategic review increase the likelihood of a takeout, and put a higher focus on removing costs, but this will take time. 2. Tractor Supply (TSCO) downgraded to Neutral from Outperform at Wedbush with analyst Seth Basham citing valuation. 3. American Water (AWK) downgraded to Neutral from Buy at BofA/Merrill with analyst Julien Dumoulin-Smith citing premium valuation and guidance fears. 4. Acuity Brands (AYI) downgraded to Neutral from Buy at Seaport Global with analyst Matt McCall citing persistent pressures expected the next 1-2 quarters and import pressure concerns. 5. Hawaiian Holdings (HA) downgraded to Hold from Buy at Argus with analyst John Staszak saying he expects Hawaiian's yields to deteriorate as both United Continental (UAL) and Southwest (LUV) enter the West Coast-to-Hawaii market. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/26/18
02/26/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Albermarle (ALB) downgraded to Underweight from Equal Weight at Morgan Stanley by analyst Vincent Andrews, who cited concerns on both the lithium supply and demand side. On the lithium demand side, bulls' electric vehicle penetration rate forecasts seem "aggressive, said Andrews. He also now has material concerns on the supply side following the recent Chilean government agreement with SQM (SQM), added Andrews. SQM was also downgraded to Underweight from Equal Weight at Morgan Stanley by analyst Javier Martinez de Olcoz Cerdan. 2. Halliburton (HAL) downgraded to Neutral from Buy at BofA/Merrill by analyst Timna Tanners, who said the U.S. shale story is maturing and there are limited catalysts for shares. Tanners expects a more muted response to high oil prices given newbuiilds coming into the market in 2018. 3. Aqua America (WTR) downgraded to Market Perform from Outperform at Wells Fargo by analyst Jonathan Reeder, who cited valuation and said he prefers shares of American Water (AWK) at current levels. 4. Mattel (MAT) downgraded to Underperform from Hold at Jefferies by analyst Stephanie Wissink. The shares currently reflect an "aggressive" sales and profit recovery to 15% margins in 2020, Wissink said, however, believes industry conditions are challenging recovery assumptions. 5. Empire State Realty (ESRT) downgraded to Hold from Buy at Stifel by analyst John Guinee, who said he expects 2018 to be a "difficult year for value creation metrics" and notes his FFO estimates continue to decline. Guinee added that the Manhattan investment market is highly competitive and that he's not convinced the company will deploy the cash balance into new investments any time soon. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/26/18
WELS
02/26/18
UPGRADE
Target $88
WELS
Outperform
American Water upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Jonathan Reeder upgraded American Water (AWK) to Outperform and raised his price target for the shares to $88 from $83. The analyst says the company is now his top water utility pick. The stock's recent underperformance has shares trading at 3%-5% price-to-earnings discounts to Aqua America (WTR) and the water utility median, Reeder tells investors in a research note. The analyst this morning also downgraded Aqua America to Market Perform.
EXC Exelon
$38.03

-0.21 (-0.55%)

01/23/18
MZHO
01/23/18
UPGRADE
Target $40
MZHO
Neutral
Exelon upgraded to Neutral at Mizuho
As previously reported, Mizuho upgraded Exelon to Neutral from Underperform and raised its price target to $40 from $37. Analyst Paul Fremont raised his earnings estimates, lowered assumed parent debt levels, and assigned a higher multiple for the merchant generation business.
12/15/17
12/15/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Morgan Stanley analyst Simon Flannery started ViaSat (VSAT) with an Equal Weight rating and $78 price target. 2. Cantor Fitzgerald analyst Elemer Piros initiated Rigel Pharmaceuticals (RIGL) with an Overweight rating and $6 price target, sayign the company is poised to achieve FDA approval of fostamatinib for lead indication immune thrombocytopenia. 3. Exelon (EXC) analyst Paul Fremont initiated Exelon with an Underperform and $36 price target to reflect expected earnings pressure from weak forward gas and power prices and high debt. 4. Credit Suisse analyst Gregory Lewis started Ocean Rig UDW (ORIG) with an Outperform rating and $32 price target, stating that the company's restructuring wiped away $3.3B in debt. 5. Barclays analyst Amir Rozwadowski started Frontier Communications (FTR) with an Underweight rating and $7 price target, as he believes the company's dividend is at risk of being cut further over the near term. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/02/18
BOFA
01/02/18
NO CHANGE
BOFA
BofA/Merrill's Top 10 US Ideas for Q1 2018
BofA/Merrill named its Top 10 Ideas for Q1 2018. They are Buy rated AMD (AMD), Disney (DIS), Exact Sciences (EXAS), Exelon (EXC), lululemon (LULU), PayPal (PYPL), United Rentals (URI), and Walmart (WMT), and Underperform rated L Brands (LB) and TripAdvisor (TRIP).
02/02/18
UBSW
02/02/18
INITIATION
Target $44
UBSW
Buy
Exelon initiated with a Buy at UBS
UBS analyst Daniel Ford started Exelon with a Buy rating and $44 price target.
NEE NextEra Energy
$154.65

-0.5 (-0.32%)

12/14/17
HDLY
12/14/17
NO CHANGE
HDLY
Hilliard Lyons Top Ideas for Year-End 2017
Hilliard Lyons Research named its Top Ideas for Year-End 2017. They are: Pinnacle Financial (PNFP), Disney (DIS), J.M. Smucker (SJM), NextEra Energy (NEE), Zoetis (ZTS), Leggett & Platt (LEG), South Jersey Industries (SJI), Tanger Factory (SKT), Physicians Realty Trust (DOC), VMware (VMW), AT&T (T), and American Water (AWK).
12/06/17
GABE
12/06/17
NO CHANGE
GABE
Buy
NextEra Energy Partners named a Best Idea for 2018 at Gabelli
Gabelli analyst Tim Winter named NextEra Energy Partners (NEP) a Best Idea in the utility sector for 2018. The analyst sees significant drop-down opportunities from sponsor and general partner NextEra Energy (NEE). The analyst rates NextEra Energy Partners with a Buy and $46 PMV.
12/07/17
FBCO
12/07/17
INITIATION
Target $173
FBCO
Outperform
NextEra Energy initiated with an Outperform at Credit Suisse
Credit Suisse analyst Michael Weinstein starts NextEra Energy with an Outperform rating and $173 price target. The analyst says the company's emphasis on a continent-wide non-regulated renewable development strategy is "extraordinary" among its integrated utility peers. He views NextEra as the "premier way to invest in a coming revolution for the electric generation industry."
02/02/18
UBSW
02/02/18
INITIATION
Target $177
UBSW
Buy
NextEra Energy initiated with a Buy at UBS
UBS analyst Daniel Ford started NextEra Energy with a Buy rating and $177 price target.
NEP NextEra Energy Partners
$39.54

-0.36 (-0.90%)

12/07/17
FBCO
12/07/17
INITIATION
Target $44
FBCO
Outperform
NextEra Energy Partners initiated with an Outperform at Credit Suisse
Credit Suisse analyst Michael Weinstein starts NextEra Energy Partners with an Outperform rating and $44 price target. The analyst views the valuation as attractive in the context of his expectations for 15% dividend growth.
12/12/17
MSCO
12/12/17
UPGRADE
MSCO
Overweight
NextEra Energy Partners upgraded to Overweight at Morgan Stanley
12/12/17
MSCO
12/12/17
UPGRADE
Target $47
MSCO
Overweight
NextEra Energy Partners upgraded to Overweight at Morgan Stanley
As previously reported, Morgan Stanley analyst Stephen Byrd upgraded NextEra Energy Partners to Overweight from Equal Weight, saying it has the clearest visibility into growth and lowest execution risk among the Yieldco stocks he covers. Byrd raised his price target on NextEra Energy Partners to $47 from $43.

TODAY'S FREE FLY STORIES

BV

BrightView

$21.95

0.14 (0.64%)

05:29
07/23/18
07/23
05:29
07/23/18
05:29
Initiation
BrightView initiated  »

BrightView initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGMO

Sangamo

$15.10

0.025 (0.17%)

05:28
07/23/18
07/23
05:28
07/23/18
05:28
Hot Stocks
Sangamo to acquire TxCell for EUR 2.58 per share in cash »

Sangamo Therapeutics and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BV

BrightView

$21.95

0.14 (0.64%)

05:27
07/23/18
07/23
05:27
07/23/18
05:27
Initiation
BrightView initiated  »

BrightView initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCM

Hutchison China MediTech

$33.92

0.89 (2.69%)

05:25
07/23/18
07/23
05:25
07/23/18
05:25
Hot Stocks
Chi-Med initiates Phase Ib/II proof-of-concept study of sulfatib »

Hutchison China MediTech,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

BJ

BJ's Wholesale

$25.90

0.23 (0.90%)

05:23
07/23/18
07/23
05:23
07/23/18
05:23
Initiation
BJ's Wholesale initiated  »

BJ's Wholesale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$0.00

(0.00%)

05:22
07/23/18
07/23
05:22
07/23/18
05:22
Hot Stocks
Roche receives CE Mark for Accu-Chek Solo micropump system »

Roche announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

PZZA

Papa John's

$51.61

0.62 (1.22%)

05:22
07/23/18
07/23
05:22
07/23/18
05:22
Hot Stocks
Papa John's adopts limited duration stockholder rights plan »

Papa John's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$279.71

-0.24 (-0.09%)

05:21
07/23/18
07/23
05:21
07/23/18
05:21
General news
Trump tells Iranian President to 'never, ever threaten' U.S. again »

President Trump tweeted…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$279.71

-0.24 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STIM

Neuronetics

$26.27

-0.44 (-1.65%)

05:19
07/23/18
07/23
05:19
07/23/18
05:19
Initiation
Neuronetics initiated  »

Neuronetics initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PZZA

Papa John's

$51.61

0.62 (1.22%)

05:17
07/23/18
07/23
05:17
07/23/18
05:17
Downgrade
Papa John's rating change  »

Papa John's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACN

Accenture

$166.47

-0.47 (-0.28%)

05:16
07/23/18
07/23
05:16
07/23/18
05:16
Hot Stocks
Accenture forms strategic alliance with Ripjar, terms not disclosed »

Accenture has formed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 06

    Aug

BV

BrightView

$21.95

0.14 (0.64%)

05:12
07/23/18
07/23
05:12
07/23/18
05:12
Initiation
BrightView initiated  »

BrightView initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCDA

Tricida

$29.50

-0.42 (-1.40%)

05:10
07/23/18
07/23
05:10
07/23/18
05:10
Initiation
Tricida initiated  »

Tricida initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BV

BrightView

$21.95

0.14 (0.64%)

05:08
07/23/18
07/23
05:08
07/23/18
05:08
Initiation
BrightView initiated  »

BrightView initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INSM

Insmed

$24.98

-0.12 (-0.48%)

05:07
07/23/18
07/23
05:07
07/23/18
05:07
Initiation
Insmed initiated  »

Insmed initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 28

    Sep

BJ

BJ's Wholesale

$25.90

0.23 (0.90%)

05:04
07/23/18
07/23
05:04
07/23/18
05:04
Initiation
BJ's Wholesale initiated  »

BJ's Wholesale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BJ

BJ's Wholesale

$25.90

0.23 (0.90%)

05:01
07/23/18
07/23
05:01
07/23/18
05:01
Initiation
BJ's Wholesale initiated  »

BJ's Wholesale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUK

Duke Energy

$80.64

-0.56 (-0.69%)

04:58
07/23/18
07/23
04:58
07/23/18
04:58
Upgrade
Duke Energy rating change  »

Duke Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

STI

SunTrust

$70.86

1.855 (2.69%)

04:55
07/23/18
07/23
04:55
07/23/18
04:55
Upgrade
SunTrust rating change  »

SunTrust upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:55
07/23/18
07/23
04:55
07/23/18
04:55
Conference/Events
RBC Capital commodity strategist to hold a dinner meeting »

Commodity Strategist…

MGEN

Miragen Therapeutics

$6.87

-0.08 (-1.15%)

04:55
07/23/18
07/23
04:55
07/23/18
04:55
Conference/Events
Miragen Therapeutics management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

04:55
07/23/18
07/23
04:55
07/23/18
04:55
General news
Breaking General news story  »

6-Month Bill Auction to…

SAR

Saratoga Investment

$24.59

0.08 (0.33%)

04:55
07/23/18
07/23
04:55
07/23/18
04:55
Conference/Events
Saratoga Investment management to meet with Compass Point »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

04:55
07/23/18
07/23
04:55
07/23/18
04:55
General news
Breaking General news story  »

3-Month Bill Auction to…

NTEC

Intec Pharma

$4.75

(0.00%)

04:55
07/23/18
07/23
04:55
07/23/18
04:55
Conference/Events
Intec Pharma management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.